RPHNEFRO (DTPA)
Pentetic acid
Image for illustration purposes only.
Presentation: Kit containing 5 vials of lyophilized powder for injectable solution. Sterile product, non-pyrogenic and under nitrogen atmosphere for complexation with the radioisotope metastable technetium-99m (99mTc).
Indications:In vivo quantitative data on glomerular filtration. Assessment of renal blood flow, parenchymal function, and permeability of the intra- and extra-renal collecting system, renal artery stenosis, and complications in kidney transplants. Direct and indirect radioisotope cystography, detection of CNS tumors, radioisotope cisternography, and pulmonary ventilation scintigraphy.
Storage: 2-8°C
Labeling volume: 1-5 mL
Labeling activity: 150 mCi
Stability post-labeling: 8 hours in room temperature (15 to 30 ºC).
Product expiration date: 24 months.
Number of vials per kit: 5
Registration: MS.1.7359.0003.001-4
AVAILABLE BY PRESCRIPTION ONLY – RESTRICTED USE TO HOSPITALS.
IF SYMPTOMS PERSIST, A DOCTOR SHOULD BE CONSULTED.
Contraindications, warnings, adverse reactions, drug interactions, precautions and posology: refer to package leaflet.
R2Pharma products are available only by means of medical prescription from a licensed physician.
IF SYMPTOMS PERSIST, A DOCTOR SHOULD BE CONSULTED.
Contraindications, warnings, adverse reactions, drug interactions, precautions and posology: refer to package leaflet.
The content of this page is destined to health professionals.